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The incorporation of noncanonical amino acids into recombinant
proteins in Escherichia coli can be facilitated by the introduction of
new aminoacyl-tRNA synthetase activity into the expression host.
We describe here a screening procedure for the identification of
new aminoacyl-tRNA synthetase activity based on the cell surface
display of noncanonical amino acids. Screening of a saturation
mutagenesis library of the E. coli methionyl-tRNA synthetase
(MetRS) led to the discovery of three MetRS mutants capable
of incorporating the long-chain amino acid azidonorleucine into
recombinant proteins with modest efficiency. The Leu-13 3 Gly
(L13G) mutation is found in each of the three MetRS mutants,
and the MetRS variant containing this single mutation is highly
efficient in producing recombinant proteins that contain
azidonorleucine.
azide–alkyne ligation  azidohomoalanine  azidonorleucine 
click chemistry
The aminoacyl-tRNA synthetases (aaRS) ensure the fidelity ofprotein synthesis in cells through specific ligation of each
amino acid to its cognate tRNA(s). Despite the specificity of
these enzymes for their natural substrates, protein engineers
have exploited the promiscuity of aaRS to incorporate a wide
array of noncanonical amino acids into recombinant proteins (1,
2). Elevation of the aaRS activity of the expression host can be
critical for efficient in vivo production of proteins in which one
of the natural amino acids is globally replaced by a noncanonical
amino acid (3–6). Alternatively, mutant aaRS activity may be
introduced into an expression host to permit incorporation of
noncanonical amino acids that are inert with respect to the
wild-type (WT) protein synthesis machinery (7–14). The discov-
ery of new mutant aaRS activities for global replacement of
natural amino acids by noncanonical counterparts can be greatly
accelerated by the efficient screening of libraries of mutant
aaRS. Such an approach has proved fruitful in generating novel
aaRS activity for the related problem of site-specific incorpo-
ration of noncanonical amino acids (15, 16). Here we describe a
rapid, f low-cytometry-based screening protocol to examine li-
braries of mutant aaRS for their ability to enable incorporation
of reactive amino acids into proteins, and we demonstrate its
application to the Escherichia coli methionyl-tRNA synthetase
(MetRS).
Our screening protocol (Fig. 1) relies on our previous obser-
vation that introduction of a noncanonical amino acid into the
E. coli cell surface protein OmpC (outer membrane protein C)
and the subsequent covalent tagging of this amino acid provides
a sensitive mode of detection of the translational activity of the
noncanonical amino acid (17, 18). E. coli cells displaying recom-
binant OmpC expressed in medium supplemented with
azidohomoalanine (AHA; 1) (Fig. 2) were covalently biotin-
ylated by means of Cu-catalyzed azide–alkyne ligation (19) and
subsequently stained with fluorescent avidin. These cells were
readily differentiable from unlabeled cells in flow-cytometric
analyses. This observation suggests that cell-surface display
should enable rapid screening for aaRS variants that activate
noncanonical amino acids with high efficiency.
As a first test of the screening protocol, we designed and built
a saturation mutagenesis library of MetRS variants. High-
resolution crystal structures of E. coliMetRS are available both
without (20) and with (21) Met bound. Additional structures are
available for MetRS bound to several analogs of Met and
methionyl-AMP (22). This wealth of structural data allows
informed selection of residues for saturation mutagenesis in the
binding pocket of MetRS. Furthermore, MetRS lacks the ‘‘sieve-
type’’ editing activity found in related aaRS such as the valyl-
(23), isoleucyl- (24), and leucyl-tRNA synthetases (25), so
engineering only of the synthetic site of the synthetase needs to
be considered. Screening of the MetRS library led to the
discovery of three different mutants that enable incorporation of
the long-chain amino acid azidonorleucine (ANL) (2) into
recombinant proteins with modest protein yields. Furthermore,
a single amino acid mutation, Leu-13 3 Gly (L13G), which
occurs in each of the three active mutants, is sufficient to
engender activity toward ANL. In fact, the L13GMetRS mutant
enables incorporation of ANL into recombinant proteins more
efficiently than any of the mutants obtained in the screen.
Results and Discussion
Cell-Surface Labeling with Biotin–Polyethyleneoxide (PEO)–Cyclooc-
tyne.We have previously labeled azide-functionalized E. coli cell
surfaces by means of copper-catalyzed azide–alkyne ligation
with biotin–PEO–propargylamide 4 as outlined in Fig. 2. As
noted, however, the requisite copper catalyst is toxic to E. coli
cells that overexpress OmpC (17, 18). Although screening
experiments have been performed successfully on cells of com-
promised viability (26), the use of live cells can greatly simplify
such screening experiments. Therefore, we investigated the
efficiency of cell-surface labeling with biotin–PEO–cyclooctyne
5, which requires no copper catalyst (27). Cells displaying OmpC
containing AHA (OmpC–AHA) were covalently biotinylated by
treatment either with 100 M CuBr, 200 M 3, and 50 M 4 for
16 h at 4°C, or with 100 M 5 for 16 h at 37°C. After staining with
fluorescent avidin, the cells were subjected to flow cytometry.
The median fluorescence of cells tagged with 5 is 35% of the
median fluorescence of cells tagged by means of the copper-
catalyzed reaction (Fig. 3) but is nevertheless 25-fold higher
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than the background fluorescence of unlabeled cells. Although
cells subjected to Cu-catalyzed azide–alkyne ligation under the
conditions described here are unable to divide, cells that have
been tagged with 5 and subjected to cell sorting are readily
regrown in selective rich medium.
MetRS Library Design and Construction. To select residues in the
binding pocket of MetRS for saturation mutagenesis, the crystal
structure of Met-bound MetRS (21) was examined by using
SWISS PDB VIEWER software (www.expasy.chspdbv). Five resi-
dues (Leu-13, Trp-253, Pro-257, Tyr-260, and His-301) were
found within a radius of 4 Å of either the sulfur atom or the
methyl group of bound Met. Alignment of MetRS sequences
from different organisms (see Fig. 7, which is published as
supporting information on the PNAS web site) reveals that
W253, Y260, and H301 are universally conserved, whereas L13
and P257 are highly conserved. These residues have been
suggested to be critical to Met binding; the backbone amide of
L13 and the hydroxyl group of Y260 form hydrogen bonds with
the sulfur atom of bound Met (21). H301 also is believed to form
a hydrogen bond to the sulfur atom, whereas W253 forms
hydrophobic contacts with the Met side chain (22). Four of these
five residues, excluding W253, were selected for mutagenesis to
all other possible amino acids; their orientations with respect to
bound Met are shown in Fig. 4. W253 was excluded from
mutagenesis because of its importance in forming the wall of the
Met-binding pocket. The library was built by means of amodified
PCR gene assembly process (see Materials and Methods) using
primers containing degenerate NNK (N is all bases; K is G,T)
codons at the mutagenesis sites. The use of NNK codons permits
complete coverage of the possible amino acid space while
eliminating two of the nonsense codons and decreasing the
Fig. 1. Protocol for screening libraries of mutant aaRS. Cells transformed with an aaRS library are induced to express OmpC in medium supplemented with a
noncanonical amino acid bearing a reactive side chain. Cells that successfully incorporate the noncanonical amino acid display the reactive side chain on their
surfaces. Labeled cells are covalently tagged by a biotin probe and subsequently stained with fluorescent avidin. Fluorescence-activated cell sorting isolates the
tagged cells from the remainder of the library. Sorted cells may be subjected to additional rounds of screening or analyzed immediately.
Fig. 2. Noncanonical amino acids and tagging reagents used in this study. (A)
1, AHA; 2, ANL; 3, Tris(triazolyl)amine ligand for copper-catalyzed azide–
alkyne ligation; 4, biotin–PEO–propargylamide; 5, biotin–PEO–cyclooctyne.
(B) Scheme for biotin tagging of azide-functionalized E. coli cell surfaces. 1 or
2 is incorporated into OmpC to display the azide on the cell surface. Cell
surface azides react either by Cu-catalyzed azide–alkyne ligation (top route)
or by strain-promoted azide–alkyne ligation (bottom route).
Fig. 3. Comparison of the extent of cell-surface labeling by Cu-catalyzed
azide–alkyne ligation and strain-promoted azide–alkyne ligation. Cells dis-
playing OmpC containing AHA were biotinylated either by means of Cu-
catalyzed azide–alkyne ligation (50 M 4, 200 M 3, and 100 M CuBr at 4°C)
(Left) or by strain-promoted azide–alkyne ligation (100 M 5 at 37°C) (Right).
Data are plotted as forward scatter (FSC; x axis), which is an indication of cell
size, vs. fluorescence (FL1; y axis). The median fluorescence of cells labeled by
means of Cu-catalyzed azide–alkyne ligation is 3-fold larger than that of cells
labeled by means of the strain-based reaction.






theoretical size of the library required for complete sequence
coverage. The library was subsequently ligated into the plasmid
pAJL-20, which encodes a variant of OmpC containing six
additional surface-exposed Met residues under inducible con-
trol, and the resulting plasmids were introduced to the Met
auxotroph M15MA.
Screening and Identification of Active Mutants. The MetRS library
was screened for evidence of efficient protein synthesis in
Met-depleted minimal medium supplemented with the long-
chain amino acid ANL. We have reported very low levels of
incorporation of ANL in cells characterized by elevated WT
MetRS activity (17), but the amounts of protein produced in such
experiments were vanishingly small. We therefore sought to
identify a MetRS mutant that would allow efficient incorpora-
tion of ANL into recombinant proteins.
An aliquot of M15MA transformed with the MetRS library in
pAJL-20 was used to inoculate minimal medium supplemented
with all 20 canonical amino acids. Upon reaching midlog phase,
the cells were washed and transferred to minimal medium
lacking Met. This culture was supplemented with high levels (8
mM) of ANL, and OmpC expression was induced by addition of
isopropyl--thiogalactoside (IPTG). The cells were treated se-
quentially with biotin–PEO–cyclooctyne 5 and fluorescent avi-
din to render fluorescent the surfaces of cells that had success-
fully incorporated ANL. The same cells also were biotinylated by
means of Cu-catalyzed azide–alkyne ligation for comparison.
Cells treated with 5were analyzed by flow cytometry, and the top
1% of the cells in the fluorescence channel were sorted and
regrown in selective liquid medium to ensure plasmid retention.
A portion of the sorted cell population also was rescued by
plating on selective agar plates, allowing analysis of single clones.
The sorted pool of cells was subjected to another round of OmpC
expression in ANL-supplemented medium and biotinylated by
means of azide–alkyne ligation to determine the extent of
enrichment of highly fluorescent clones. Although only 1% of
the cells in the original library resided in the high-fluorescence
regime (80 arbitrary fluorescence units), 40% of the sorted
cells fell in this range, demonstrating selective enrichment of
highly fluorescent clones (Fig. 5 A and B). Two individual clones
from this population (clones 2.6.1 and 2.6.2) retained the high
fluorescence characteristic of extensive azide functionalization
of the cell surface (Fig. 5 C and D) and were analyzed further.
In addition, the plasmid DNA from the pooled sorted cells was
isolated, and the MetRS genes were moved into a variant of the
plasmid pAJL-20 encoding an OmpC with only two additional
Met sites in its exposed loops (as opposed to the six additional
sites previously used). These plasmids were reintroduced to
M15MA, and the screening protocol was carried out as described
above, except that ANL was added at a concentration of 3.2 mM.
This screen yielded one additional highly fluorescent mutant,
clone 3.2.7.
The MetRS mutations found in these three clones are pre-
sented in Table 1. The net effect of these mutations is an
expansion of the binding pocket to create room for the bulky
substrate ANL. The character of the binding pocket remains
hydrophobic. Most striking is the recurrence of the L13G
mutation, which is present in all three mutants analyzed. The
L13G MetRS single mutant therefore was constructed and
tested for its ability to incorporate ANL as described below.
Recombinant Protein Production with MetRS Mutants. Each of the
four MetRS mutants (clones 2.6.1, 2.6.2, and 3.2.7 and L13G)
was transferred to the plasmid pAJL-61, which encodes a
6xHis-tagged dihydrofolate reductase (DHFR) under inducible
control as well as the repressor protein lacIq. The resulting
plasmids were transformed into the expression host M15MA,
which also contains a plasmid-borne copy of lacIq. The high
levels of lacIq were introduced to minimize leaky expression of
DHFR, because any DHFR produced before induction will not
contain ANL. Midlog phase cultures of M15MA[pAJL-61] were
shifted to minimal medium lacking Met but supplemented with
8 mM ANL as described inMaterials and Methods. After 3 h, the
cells were lysed, and the DHFR was purified by using Ni–
nitrilotriacetic acid (NTA) chromatography. The yield of protein
produced per liter of culture was calculated by measuring the
A280 value of a solution of the purified protein, and the extent of
incorporation of ANL was estimated by N-terminal sequencing
(Table 2). The L13G mutant enables the most efficient incor-
poration of ANL; 95% of the N-terminal Met is replaced by
Fig. 4. Residues in the Met-binding pocket of MetRS selected for saturation
mutagenesis. Four residues (stick models) found within 4 Å of the sulfur atom
or methyl group of Met (space-filling model) were mutated to all other
possible amino acids. Figure was drawn from coordinates in ref. 21 (Protein
Data Bank ID code 1F4L).
Fig. 5. Fluorescence histograms of cells induced to produce OmpC in me-
dium supplemented with ANL. All cells were biotinylated by means of Cu-
catalyzed azide–alkyne ligation before flow cytometry. (A) Cells harboring
naı¨ve MetRS library. (B) Cells enriched from the top 1% of cells in A. (C) Cells
harboring clone 2.6.1 MetRS. (D) Cells harboring clone 2.6.2 MetRS.
Table 1. Mutations found in MetRS clones that enable
incorporation of ANL into recombinant proteins
MetRS Leu-13 Pro-257 Tyr-260 His-301
2.6.1 G L T A
2.6.2 G S T L
3.2.7 G L L V
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ANL in cells that express this mutant. Met was the only other
amino acid detected above background in N-terminal sequenc-
ing analyses. SDSPAGE analysis of whole-cell lysates from
M15MA[pAJL-20] cells harboring the L13G mutant demon-
strates that comparable amounts of DHFR are produced when
the cells are supplemented with either Met or ANL (Fig. 6). The
yields of purified protein obtained from experiments using the
L13Gmutant are within a factor of 2 of the protein yield of native
DHFR produced with WT MetRS (27) and are sufficient for
demanding applications such as biomaterials synthesis.
In Vitro Activation Kinetics of L13GMetRS. Previous work has shown
that the rates of activation of Met analogs correlate strongly with
the efficiencies with which those analogs are incorporated into
recombinant proteins (27, 28). The kinetic parameters for
activation of both Met and ANL were determined by using the
purified L13G mutant of MetRS (Table 3). Met is still activated
by the mutant synthetase, although the specificity constant
kcatKm is nearly 300-fold smaller than that characteristic of the
WT enzyme. Nevertheless, the activation rate of ANL by the
L13G mutant (1.56  103 M1s1) compares favorably with
the rates previously determined for the activation of the excel-
lent Met surrogates AHA and homopropargylglycine by the WT
MetRS (28). We have reported that activation of ANL by WT
MetRS is undetectable in similar assays (18).
Conclusions
We have presented a rapid, high-throughput screening method
for the identification of new aaRS activities in vivo. By using this
screening protocol, we have identified three mutants of the E.
coli MetRS that enable incorporation of the long-chain amino
acid ANL into recombinant proteins in response to Met codons.
The L13G mutation occurs in each of these three mutants, and
the MetRS variant harboring this single amino acid mutation
proves to be the most efficient synthetase for incorporation of
ANL into recombinant proteins. The expanded binding pocket
of L13G MetRS may permit incorporation of other long-chain
amino acids into recombinant proteins.
A relatively small library of 106 members was screened in the
current study, but the ultra-high-throughput nature of the flow
cytometric screen should permit analysis of libraries several
orders of magnitude larger, up to the limits of bacterial trans-
formation efficiency. Protocols of the kind described here need
not be limited to azide-bearing amino acids and may be readily
adapted to other reactive amino acid side chains.
Materials and Methods
Amino Acids and Tagging Reagents. AHA (1) (29), ANL (2) (18),
biotin–PEO–propargylamide 4 (17), biotin–PEO–cyclooctyne 5
(30), and the Tris(triazolyl)amine ligand 3 (19, 31) were prepared
as described. CuBr (99.999% purity) was purchased from
Aldrich.
MetRS Library Construction. Restriction enzymes were from New
England Biolabs or Roche. T4 DNA ligase was purchased from
Invitrogen or New England Biolabs. The plasmid pAJL-20 was
used as a template for construction of the MetRS library.
pAJL-20 has been described (18) and encodes a variant of OmpC
under control of the isopropyl--thiogalactoside (IPTG)-
inducible T5 promoter. In addition, pAJL-20 contains a cassette
encoding the E. coli MetRS under control of its natural pro-
moter. Oligonucleotides encoding degenerate NNK (N is
A,T,G,C; K is G,T) codons at the sites corresponding to Leu-13,
Pro-257, Tyr-260, and His-301 in E. coli MetRS were obtained
from Qiagen (Valencia, CA). Four separate PCRs were per-
formed with PicoMaxx polymerase (Stratagene) by using
pAJL-20 as a template and the following pairs of primers: Nhe
lib forward and L13 reverse, L13 forward and P257 reverse, P257
forward and H301 reverse, H301 forward and lib reverse. The
P257 forward and P257 reverse primers span both the Pro-257
and the Tyr-260 codons. Sequences for all primers may be found
in Supporting Text, which is published as supporting information
on the PNAS web site. The DNA fragments obtained from these
PCRs were electrophoresed and purified by using Zymo-spin
columns (Zymo Research, Orange, CA). Equimolar quantities
(10 fmol) of the fragments were mixed and subjected to 10
rounds of PCR (95°C for 1 min, 55°C for 1 min, 72°C for 2 min)
by using PicoMaxx as the polymerase. The primers Nhe lib
forward and lib reverse were subsequently added, and the
reaction mixture was subjected to 30 more rounds of PCR using
the same parameters described above. The resulting 1.4-kb PCR
product was digested with NotI and BsrGI and ligated into
pAJL-20 digested with the same enzymes. The ligation mixture
was transformed into chemically competent XL-1 Blue cells
(Stratagene), yielding 106 independent transformants for a max-
imum of 62% coverage of the library. The plasmid DNA from
the pooled transformants was isolated with Maxiprep (Qiagen),
diluted 10-fold with water, and used to transform the Met
auxotroph M15MA through electroporation, yielding 5  106
independent clones. Aliquots of cultures containing the pooled
transformants (500 l) were mixed with 500 l of frozen stock
solution (65% glycerol25 mMTris100 mMMgSO4) and stored
at 80°C until needed.
Other Plasmids. The XL-1 Blue strain of E. coli (Stratagene) was
used for all recombinant DNA manipulations. The plasmid
Table 3. Kinetic parameters for activation of Met, 1 and 2 by WT
and L13G MetRS
Amino acid Synthetase kcat, s1 Km, M kcatKm, M1s1
Met WT* 13.3 24.3 5.47  101
AHA (1) WT* 4.71 3328 1.42  103
Met L13G 4.27 2109 2.02  103
ANL (2) L13G 7.53 4831 1.56  103
*From refs. 31 and 32.
Table 2. Purified protein yield and extent of incorporation








Clone 2.6.1 4.5 55
Clone 2.6.2 3.2 39
Clone 3.2.7 1.5 —†
L13G 18.1 95
*No protein was detected.
†Not determined.
Fig. 6. SDSPAGE analysis of whole-cell lysates of M15MA[pAJL-61] encod-
ing the L13G MetRS mutant. (Lane 1) Molecular weight marker. Cells were
grown to midlog phase in medium containing all 20 canonical amino acids and
then shifted to 19-aa medium (no Met) supplemented with 40 mgliter Met
(lane 2), 172 mgliter ANL (lane 3), or no amino acid (lane 4). Expression of
DHFR is comparable in the cultures supplemented either with Met or ANL.






pAJL-61 is functionally equivalent to the previously described
pQE-15 MRS (3) except that it encodes a copy of the lac
repressor protein lacIq. pAJL-61 was constructed by digesting the
0.6-kb DHFR coding region from pQE-15 MRS with BamHI
and HindIII. This fragment was ligated into similarly digested
pQE-80L (Qiagen) to generate pAJL-60. The 2.5-kb cassette
encodingMetRS was isolated from pQE-15MRS upon digestion
with NheI and was ligated into NheI-digested pAJL-60 to
generate pAJL-61. The plasmid pAJL-80 encodes a 551-aa
variant of MetRS bearing a C-terminal 6xHis-tag for affinity
purification. A 1.7-kb DNA fragment was amplified from
pAJL-20 by using the primers Cterm MRS forward and Cterm
MRS reverse (see Supporting Text for sequences). This fragment
was digested with BsaI and BglII and subsequently ligated to
pQE-60 (Qiagen) digested with NcoI and BglII to generate
pAJL-80. The plasmid pAJL-84 encodes the L13G mutant of
MetRS and was generated by using QuikChange site-directed
mutagenesis with the primers L13G forward and L13G reverse
(see Supporting Text). The integrity of all constructs was con-
firmed by DNA sequencing.
OmpC Expression and Cell-Surface Labeling. The expression of
recombinant OmpC containing either AHA or ANL was carried
out essentially as described (17). Briefly, 30 ml of M9 medium
(M9 salts0.2% glucose1 mM MgSO425 mg/liter thiamine)
supplemented with 40 mgliter of each of the 20 canonical amino
acids, 200 mgliter ampicillin, and 35 mgliter kanamycin was
inoculated with either 400 l of an overnight culture of
M15MA[pAJL-20] or with a 1-ml aliquot of M15MA trans-
formed with the MetRS library. When the OD600 of these
cultures reached 0.9–1.0, the cells were pelleted by centrifuga-
tion at 5,000  g for 5 min. The cells were resuspended in 30 ml
of M9 medium supplemented with 19 aa (no Met) and incubated
with shaking for 10 min at 37°C. The cells were pelleted again
and resuspended in fresh M9 medium supplemented with 19 aa.
The resulting cultures were divided into four 5-ml aliquots, which
were supplemented with the following: Met (0.27 mM, 40
mgliter), AHA (0.28 mM, 40 mgliter), ANL (8 mM, 1.38
gliter), or no analog. Expression of recombinant OmpC was
induced at 37°C upon addition of IPTG to a final concentration
of 1 mM. After 3 h, a 1-ml sample of each culture was pelleted
and washed with 1 ml of sterile PBS (pH 7.4). The surfaces of
these cells were tagged either by means of Cu-catalyzed azide–
alkyne ligation or by treatment of the cells with biotin–PEO–
cyclooctyne. For the Cu-catalyzed reaction, the cells were
treated with 50 M biotin–PEO–propargylamide, 200 M tria-
zole ligand, and 100 M CuBr, which was delivered as an
aqueous suspension as described (18). The Cu-catalyzed reaction
proceeded for 16 h at 4°C with agitation. Alternatively, 1 ml of
the washed cells was treated with 100 M biotin–PEO–
cyclooctyne for 16 h at 37°C with agitation. After the labeling
reaction, the cells were washed twice more with 1 ml of PBS and
treated with 2.5 l of a 1 mgml solution of an avidin–Alexa
Fluor 488 conjugate (Molecular Probes) for 2 h at 4°C with
agitation. The cells were washed three more times with 1 ml of
PBS to remove nonspecifically bound avidin.
Flow Cytometry and Cell Sorting.All flow-cytometric analyses were
carried out on a DAKO MoFlo cell sorter equipped with an
argon ion laser emitting at 488 nm. All sorting was performed in
sort single mode. Sort gates were set, and data analysis was
performed with SUMMIT software (DAKO). Highly fluorescent
cells were sorted from libraries expressing OmpC containing
ANL by setting a gate in the fluorescence channel corresponding
to the top 1% of the cells. Additional gates were set in the
forward- and side-scatter channels to exclude scatterers of
unusually large size. Approximately 105 cells were collected in a
typical experiment, and 2–3  103 of the sorted cells were
reanalyzed to check the quality of the sort. The remaining sorted
cells were rescued upon inoculation into 10 ml of 2xYT medium
supplemented with 200 mgliter ampicillin and 35 mgliter
kanamycin. The regrown pools of cells were mixed 1:1 with
frozen stock buffer and stored at 80°C. Alternatively, the
sorted cells were plated on 2xYT agar supplemented with the
same antibiotics to facilitate analysis of individual clones.
Recombinant DHFR Expression, Purification, and Analysis. DHFR
containing ANL was produced from M15MA[pAJL-61] and its
variants harboring selected MetRS mutants under the culture
conditions described above. The concentration of ANL was
decreased to 1 mM (172 mgliter) for production of DHFR in
cells harboring the L13G mutant of MetRS. After protein
expression, 10 ml of culture was pelleted and resuspended in 8
M urea. DHFR was purified under denaturing conditions by
using Ni-NTA spin columns (Qiagen) as directed by the manu-
facturer. N-terminal sequencing was performed by the Peptide
and Protein Microanalysis Laboratory at the California Institute
of Technology. Protein yields were determined by measuring the
A280 of a solution of the purified protein, assuming an extinction
coefficient of 32,693 M1cm1. Because ANL does not exhibit
appreciable absorbance at 280 nm, the extinction coefficient was
assumed to remain constant across samples of DHFR with
differing extents of ANL incorporation.
MetRS Expression, Purification, and Activation Assays. Superbroth
medium (2 liters) was inoculated with 10 ml of an overnight
culture of E. coli strain XL-1 Blue[pAJL-84]. When the culture
reached an OD600 of 1.0, IPTG was added to a final concentra-
tion of 1 mM, and protein expression was induced at 37°C for 5 h.
The cells were harvested by centrifugation (6,000 g for 15min).
His-tagged MetRS was isolated under native conditions on
Ni-NTA agarose (Qiagen) according to the manufacturer’s
recommendations. The column eluent was buffer-exchanged
into storage buffer (50 mM Tris1 mM DTT) by using Bio-Rad
PD-10 columns. The eluent was added to an equal mass of
glycerol, mixed thoroughly, and frozen at 80°C until needed.
Activation assays were carried out as described (32). The Met
concentrations tested ranged from 150 M to 5mM, whereas the
ANL concentrations ranged from 625 M to 20 mM. The L13G
mutant of MetRS was added to all reactions at a concentration
of 100 nM. Data were fit to the Michaelis–Menten model by
using SIGMAPLOT (SPSS, Chicago) software.
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